TENX · NASDAQ
Tenax Therapeutics (TENX) Stock Price & Fundamentals
Tenax Therapeutics (TENX) closed at $800.99 on Oct 9, 2026, up 0.68% from the previous close of $795.59.
Share price, past year
1Y +17.47%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $800.99 |
| Sep 30, 2026 | $781.68 |
| Aug 31, 2026 | $740.45 |
| Jul 31, 2026 | $696.01 |
| Jun 30, 2026 | $715.48 |
| May 29, 2026 | $677.39 |
| Apr 30, 2026 | $640.07 |
| Mar 31, 2026 | $649.37 |
| Feb 27, 2026 | $639.80 |
| Jan 30, 2026 | $680.98 |
| Dec 31, 2025 | $674.92 |
| Nov 28, 2025 | $680.68 |
| Oct 31, 2025 | $665.12 |
Key statistics
- Market cap
- $25.59B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.49
- Revenue (TTM)
- —
- Net income (TTM)
- −$64.86M
- Shares outstanding
- 31.9M
- Dividend yield
- —
- 52-week range
- $633.10 – $800.99
Tenax Therapeutics's market cap is $25.59B, based on a share price of $800.99 and 31.9M shares outstanding as of Jun 30, 2026.
Financials
Tenax Therapeutics reported revenue of $0.00 for fiscal 2025.
Tenax Therapeutics reported a net loss of $52.60M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $0.00 | — | −$52.60M | — | −$1.34 | — |
| FY2024ended Dec 31, 2024 | $0.00 | — | −$17.60M | — | −$1.15 | — |
| FY2016ended Dec 31, 2016 | $0.00 | −100.0% | −$43.92M | — | −$31.24 | −$15.87M |
| FY2015ended Apr 30, 2015 | $49.29K | −69.0% | — | — | −$0.50 | −$9.75M |
| FY2014ended Apr 30, 2014 | $158.93K | −86.7% | — | — | — | −$9.27M |
| FY2013ended Apr 30, 2013 | $1.19M | +227.4% | — | — | — | −$4.94M |
| FY2012ended Apr 30, 2012 | $363.78K | +252.6% | — | — | — | — |
| FY2011ended Apr 30, 2011 | $103.17K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $0.00 | −$15.72M | −$0.35 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$10.41M | −$0.28 |
| Q4 FY2015ended Apr 30, 2015 | $49.29K | — | — |
| Q3 FY2015ended Jan 31, 2015 | $0.00 | — | — |
| Q2 FY2015ended Oct 31, 2014 | $0.00 | — | — |
| Q1 FY2015ended Jul 31, 2014 | $0.00 | — | — |
| Q3 FY2014ended Jan 31, 2014 | $41.86K | — | — |
| Q2 FY2014ended Oct 31, 2013 | $55.71K | — | — |
Company profile
- Name
- Tenax Therapeutics, Inc.
- Ticker
- TENX
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 101 Glen Lennox Drive, Suite 300, Chapel Hill, NC 27517
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000034956
Recent SEC filings
- Oct 8, 2026
- Sep 9, 2026
- Aug 10, 2026
- Jul 31, 2026
- Jul 31, 2026
- Jul 2, 2026
- Jun 30, 2026
- Jun 29, 2026
Frequently asked questions
What is Tenax Therapeutics's stock price?
Tenax Therapeutics (TENX) closed at $800.99 on Oct 9, 2026, up 0.68% from the previous close of $795.59.
What is Tenax Therapeutics's market cap?
Tenax Therapeutics's market cap is $25.59B, based on a share price of $800.99 and 31.9M shares outstanding as of Jun 30, 2026.
How much revenue does Tenax Therapeutics make?
Tenax Therapeutics reported revenue of $0.00 for fiscal 2025.
Does Tenax Therapeutics pay a dividend?
Tenax Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Tenax Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures